Furthermore, GLP-1 has been shown to have neuroprotective properties , including anti-inflammatory effects and promotion of neuronal survival
"A double-blind, cross-over, study of oral N-acetylcysteine in Sjogren's syndrome." Scand J Rheumatol Suppl
GLP-1 receptor agonists are large, water-loving peptides, and the skin's outer barrier is built to block exactly those molecules
However, it adds a second mechanism by activating GIP receptors
The initial phase of any new medication can bring about a period of adjustment as your body learns to process and react to the new compound
however, it is important to note that these symptoms typically diminish with time and resolve on their own